▶ 調査レポート

世界の尿路感染症検査市場（2023～2030）：種類別（膀胱炎、腎盂腎炎、尿道炎）、検査別（膀胱鏡尿路感染症検査、腎臓・膀胱超音波尿路感染症検査、研究所検査）、エンドユーザー別
• 英文タイトル：Urinary Tract Infection Testing Market by Type (Cystitis, Pyelonephritis, Urethritis), Test (Cystoscopy Urinary Tract Infection Testing, Kidney & Bladder Ultrasound Urinary Tract Infection Testing, Laboratory Test), End-Use - Global Forecast 2023-2030

360iResearchが調査・発行した産業分析レポートです。世界の尿路感染症検査市場（2023～2030）：種類別（膀胱炎、腎盂腎炎、尿道炎）、検査別（膀胱鏡尿路感染症検査、腎臓・膀胱超音波尿路感染症検査、研究所検査）、エンドユーザー別 / Urinary Tract Infection Testing Market by Type (Cystitis, Pyelonephritis, Urethritis), Test (Cystoscopy Urinary Tract Infection Testing, Kidney & Bladder Ultrasound Urinary Tract Infection Testing, Laboratory Test), End-Use - Global Forecast 2023-2030 / MRC2311A0121資料のイメージです。• レポートコード：MRC2311A0121
• 出版社/出版日：360iResearch / 2023年10月25日
• レポート形態：英文、PDF、195ページ
• 納品方法：Eメール（受注後2-3日）
• 産業分類：医療
• 販売価格（消費税別）
  Single User（1名利用、印刷不可、1年間閲覧）￥592,350 (USD3,949)▷ お問い合わせ
  Site License（同一拠点内共有可、印刷可）￥1,042,350 (USD6,949)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
尿路感染症検査市場規模は、2022年に5億1,869万米ドルと推定され、2023年には5億7,159万米ドルに達すると予測され、CAGR 10.67%で2030年には11億6,786万米ドルに達すると予測されます。
市場細分化とカバー範囲：
この調査レポートは、尿路感染症検査市場の包括的な見通しを提供するために、様々なサブ市場を分析し、収益を予測し、各カテゴリの新たな動向を調査しています。
● タイプ別では、膀胱炎、腎盂腎炎、尿道炎、膣炎について調査しています。尿道炎は予測期間中に大きな市場シェアを獲得すると予測されます。
● 検査別では、膀胱鏡尿路感染症検査、腎臓・膀胱超音波尿路感染症検査、ラボラトリー検査、非ラボラトリー検査、核医学スキャン尿路感染症検査、感受性尿路感染症検査、尿検査尿路感染症検査、尿培養尿路感染症検査、排尿膀胱尿道造影（VCUG）尿路感染症検査について調査しています。予測期間中、尿路感染症検査は大きな市場シェアを占めると予測されます。
● エンドユーザー別では、アカウンタブル・ケア・オーガニゼーション、一般開業医、病院救急部、 病院検査室、レファレンス検査室、緊急医療、泌尿器科医、泌尿器科医が調査対象です。泌尿器科医は予測期間中に大きな市場シェアを占めると予測されています。
● 地域別では、南北アメリカ、アジア太平洋、ヨーロッパ、中東、アフリカで調査を行いました。詳しい内訳は、南北アメリカはアルゼンチン、ブラジル、カナダ、メキシコ、アメリカを対象に、アメリカはさらにカリフォルニア、フロリダ、イリノイ、ニューヨーク、オハイオ、ペンシルバニア、テキサスを対象に調査を行いました。アジア太平洋地域は、オーストラリア、中国、インド、インドネシア、日本、マレーシア、フィリピン、シンガポール、韓国、台湾、タイ、ベトナムでした。ヨーロッパ・中東・アフリカは、デンマーク、エジプト、フィンランド、フランス、ドイツ、イスラエル、イタリア、オランダ、ナイジェリア、ノルウェー、ポーランド、カタール、ロシア、サウジアラビア、南アフリカ、スペイン、スウェーデン、スイス、トルコ、アラブ首長国連邦、イギリスを対象としています。2022年の市場シェアは南北アメリカが38.74%で最大、次いでヨーロッパ、中東・アフリカでした。

市場統計：
本レポートでは、主要7通貨（米ドル、ユーロ、日本円、英ポンド、豪ドル、カナダドル、スイスフラン）の市場規模と予測を提供しています。本レポートでは、2018年から2021年を過去年、2022年を基準年、2023年を推定年、2024年から2030年を予測期間としています。

FPNVポジショニングマトリックス：
FPNVポジショニングマトリックスは、尿路感染症検査市場を評価するための不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります： フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析：
市場シェア分析では、尿路感染症検査市場のベンダーランドスケープに関する貴重な洞察を提供します。全体的な収益、顧客基盤、その他の主要指標に対する影響を評価することで、各社の業績と直面している競争環境について包括的な理解を提供します。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競争レベルも明らかにします。

主要企業のプロフィール：
本レポートでは、尿路感染症検査市場における最近の重要な動向を掘り下げ、主要ベンダーとその革新的なプロフィールを紹介しています。これには、Accelerate Diagnostics, Inc., ACON Laboratories, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., bioMérieux SA, Chungdo Pharm Co., Ltd., F. Hoffmann-La Roche Ltd., Genetworx, LLC, Module Innovations Pvt. Ltd., QIAGEN GmbH, Randox Laboratories Ltd., Siemens Healthcare GmbH, T2 Biosystems, Inc., and Thermo Fisher Scientific Inc.などが含まれます。

本レポートでは、以下の点について貴重な洞察を提供しています：
1. 市場浸透： 主要企業の市場ダイナミクスと製品に関する包括的な情報を提供します。
2. 市場開拓： 新興市場と成熟市場セグメントへの浸透を詳細に分析し、有利な機会を強調します。
3. 市場の多様化： 新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報を記載しています。
4. 競合他社の評価とインテリジェンス： 主要企業の市場シェア、戦略、製品、認証、規制当局の承認、特許状況、製造能力を網羅的に評価しています。
5. 製品開発とイノベーション： 将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を行いました。

本レポートは、以下のような主要な質問に対応しています：
1. 尿路感染症検査市場の市場規模および予測はどのようになっていますか？
2. 尿路感染症検査市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野はどこですか？
3. 尿路感染症検査市場の機会を特定するための競争戦略窓口はどのようになっていますか？
4. 尿路感染症検査市場における最新の技術動向と規制の枠組みはどのようになっていますか？
5. 尿路感染症検査市場における主要ベンダーの市場シェアはどのようになっていますか？
6. 尿路感染症検査市場への参入に適したモードと戦略的動きはどのようになっていますか？

1. 序論
2. 調査方法
3. エグゼクティブサマリー
4. 市場概要
5. 市場インサイト
6. 尿路感染症検査の市場分析：種類別
7. 尿路感染症検査の市場分析：検査別
8. 尿路感染症検査の市場分析：エンドユーザー別
9. 南北アメリカの尿路感染症検査市場
10. アジア太平洋の尿路感染症検査市場
11. ヨーロッパ・中東・アフリカの尿路感染症検査市場
12. 競争状況
13. 競争ポートフォリオ
14. 付録

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Urinary Tract Infection Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of urinary tract infections among geriartic and women
5.1.1.2. Prevalence of diabetes and kidney stones
5.1.1.3. Favorable investments by the government to increase rapid diagnostics
5.1.2. Restraints
5.1.2.1. Product recall and lack of awareness among the people
5.1.3. Opportunities
5.1.3.1. Increasing launch of combination drugs
5.1.3.2. Development of new imaging technologies and testing devices
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Urinary Tract Infection Testing Market, by Type
6.1. Introduction
6.2. Cystitis
6.3. Pyelonephritis
6.4. Urethritis
6.5. Vaginitis
7. Urinary Tract Infection Testing Market, by Test
7.1. Introduction
7.2. Cystoscopy Urinary Tract Infection Testing
7.3. Kidney & Bladder Ultrasound Urinary Tract Infection Testing
7.4. Laboratory Test
7.5. Non-Laboratory Test
7.6. Nuclear Scans Urinary Tract Infection Testing
7.7. Susceptibility Urinary Tract Infection Testing
7.8. Urinalysis Urinary Tract Infection Testing
7.9. Urine Culture Urinary Tract Infection Testing
7.10. Voiding Cystourethrogram (VCUG) Urinary Tract Infection Testing
8. Urinary Tract Infection Testing Market, by End-Use
8.1. Introduction
8.2. Accountable Care Organizations
8.3. General Practitioners
8.4. Hospital Emergency Departments
8.5. Hospital Laboratories
8.6. Reference Laboratories
8.7. Urgent Care
8.8. Urogynecologists
8.9. Urologists
9. Americas Urinary Tract Infection Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Urinary Tract Infection Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Urinary Tract Infection Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Accelerate Diagnostics, Inc.
13.1.2. ACON Laboratories, Inc.
13.1.3. Beckman Coulter, Inc.
13.1.4. Bio-Rad Laboratories, Inc.
13.1.5. bioMérieux SA
13.1.6. Chungdo Pharm Co., Ltd.
13.1.7. F. Hoffmann-La Roche Ltd.
13.1.8. Genetworx, LLC
13.1.9. Module Innovations Pvt. Ltd.
13.1.10. QIAGEN GmbH
13.1.11. Randox Laboratories Ltd.
13.1.12. Siemens Healthcare GmbH
13.1.13. T2 Biosystems, Inc.
13.1.14. Thermo Fisher Scientific Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

TABLE 1. URINARY TRACT INFECTION TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. URINARY TRACT INFECTION TESTING MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URETHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. URINARY TRACT INFECTION TESTING MARKET SIZE, BY VAGINITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 11. URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTOSCOPY URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. URINARY TRACT INFECTION TESTING MARKET SIZE, BY KIDNEY & BLADDER ULTRASOUND URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. URINARY TRACT INFECTION TESTING MARKET SIZE, BY LABORATORY TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. URINARY TRACT INFECTION TESTING MARKET SIZE, BY NON-LABORATORY TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. URINARY TRACT INFECTION TESTING MARKET SIZE, BY NUCLEAR SCANS URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUSCEPTIBILITY URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINALYSIS URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINE CULTURE URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. URINARY TRACT INFECTION TESTING MARKET SIZE, BY VOIDING CYSTOURETHROGRAM (VCUG) URINARY TRACT INFECTION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. URINARY TRACT INFECTION TESTING MARKET SIZE, BY ACCOUNTABLE CARE ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. URINARY TRACT INFECTION TESTING MARKET SIZE, BY GENERAL PRACTITIONERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL EMERGENCY DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. URINARY TRACT INFECTION TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. URINARY TRACT INFECTION TESTING MARKET SIZE, BY URGENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. URINARY TRACT INFECTION TESTING MARKET SIZE, BY UROGYNECOLOGISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. URINARY TRACT INFECTION TESTING MARKET SIZE, BY UROLOGISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 39. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 41. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 44. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 58. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 61. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 67. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 73. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 76. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 79. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 82. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 85. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 88. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 95. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 98. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 101. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 102. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 104. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 105. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 107. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 110. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 113. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 119. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 120. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 122. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 125. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 126. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 128. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 132. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 137. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 138. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 140. SPAIN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 143. SWEDEN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 144. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 146. SWITZERLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 147. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 149. TURKEY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 156. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 157. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 158. URINARY TRACT INFECTION TESTING MARKET LICENSE & PRICING

以下、関連資料のご紹介